United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
37.65%
Price
12:06
€501.60
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for United Therapeutics has seen massive gains of 37.65%. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.647% | 2.647% |
| iShares Core DAX® | 3,59 % | 6,43 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % |
| iShares S&P 500 | 4,14 % | 4,94 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
15.58%
12:06
12:06
